Agilon Health (AGL) Equity Average (2020 - 2026)

Agilon Health has reported Equity Average for 7 years, with the latest figure at $154.1 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 68.27% year-over-year to $154.1 million; the trailing twelve-month figure through Mar 2026 stood at $154.1 million (down 68.27% YoY), and the FY2025 full-year result was $298.8 million, down 47.2% from the prior year.
• Equity Average for Q1 2026 stood at $154.1 million, down from $216.4 million in the prior quarter.
• The five-year high for Equity Average was $1.1 billion in Q2 2022, with the low at $154.1 million in Q1 2026.
• Historically, Equity Average has averaged $719.0 million across 5 years, with a median of $682.2 million in 2024.
• Annual changes were most pronounced in 2022 — Equity Average soared 477.9% — and 2026, when it tumbled 68.27%.
• Agilon Health's Equity Average stood at $1.1 billion in 2022, then retreated by 27.91% to $766.3 million in 2023, then sank by 31.76% to $522.9 million in 2024, then tumbled by 58.62% to $216.4 million in 2025, then fell by 28.8% to $154.1 million in 2026.
• The last three Equity Average figures came in at $154.1 million (Q1 2026), $216.4 million (Q4 2025), and $357.5 million (Q3 2025), per Business Quant data.